Download presentation
Presentation is loading. Please wait.
Published byDonald McLaughlin Modified over 8 years ago
1
What we will review this lecture: Receptor Tyrosine Kinase signalling: PI3K Pathway – AKT, PDK1, PTEN RTK Signalling in Cancer Historical description of BCR-ABL
2
Friedrich Grimminger, Ralph T. Schermuly & Hossein A. Ghofrani. Nature Reviews Drug Discovery 9, 956-970
7
CML: Chronic Myelogenous Leukemia – Asymptomatic at time of diagnosis Abnormal white blood cell count Stable for 3 – 5 years followed by “Blast Crisis” Fatal within 3 – 6 months of Blast crisis 20% of all leukemia's 5000 cases per year in US (compare with 180,000 lung cancer cases)
8
CML: Chronic Myelogenous Leukemia – All CML cells harbor Philadelphia chromosome 1960: Peter Nowell David Hungerford Nowell P, Hungerford D. "A minute chromosome in chronic granulocytic leukemia." Science 1960;132:1497.
9
1973: Janet D. Rowley Discovered t(9;22) Rowley JD. "A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining [letter]". Nature 1973;243:290–3.
16
c-Abl Kinase Domain Structure
17
STI-571
19
www.cmlsupport.com
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.